ST
Somite Therapeutics, Inc.
SEC filingOther · Boston, MA
Amount raised$47.5Msold at filing
Total offering$47.5M
Investors in the raise30count reported to the SEC
FiledNov 26, 2025first sale Apr 11, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Steven HoltzmanDirector
Chad CowanDirector
Micah BreakstoneExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.